nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.17650/2311-1267-2015-1-75-80nodgo-82Research ArticleОригинальные исследованияИзолированная нейтропения у детей: от педиатра к гематологу (обзор литературы)Isolated neutropenia in children: from the pediatrician to a hematologist (literature review)ЮдинаНаталья БорисовнаYudinaN. B.

Россия, 394087, Воронеж, ул. Ломоносова, 114

114 Lomonosov St., Voronezh, 394087, Russia

n.yudina@list.ruБрежневаН. В.BrezhnevaN. V.

Россия, 394087, Воронеж, ул. Ломоносова, 114

114 Lomonosov St., Voronezh, 394087, Russia

БУЗ Воронежской области «Воронежская областная детская клиническая больница № 1»РоссияVoronezh Regional Children's Clinical Hospital № 1Russian Federation201523052015217580Copyright © Юдина Н.Б., Брежнева Н.В., 20152015Юдина Н.Б., Брежнева Н.В.Yudina N.B., Brezhneva N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/82

В практике детского гематолога пациенты с изолированной нейтропенией занимают определенное место, на их долю приходится около 15–20 % случаев всех обращений на консультацию к гематологу или педиатру. «Реактивный лимфоцитоз» – наиболее распространенная трактовка этого состояния специалистами «негематологического» профиля, которая приводит к определенному замешательству. В статье представлен обзор литературы с акцентом на проблему приобретенной изолированной нейтропении у детей, которая не связана с врожденной и приобретенной миелосупрессией, синдромами врожденной нейтропении, гиперспеленизмом.

In the practice of pediatric hematologist, patients with isolated neutropenia occupy a certain place and account for about 15–20 % of all requests for a consultation with a hematologist or a pediatrician. “Reactive lymphocytosis” is the most common interpretation of this state by experts of “hematological” type, which leads to a certain confusion. The article presents a review of the literature with an emphasis on the problem of acquired isolated neutropenia in children, which is not associated with congenital and acquired myelosuppression, congenital neutropenia syndromes, and hyperspelenism.

транзиторная нейтропенияхроническая аутоиммунная нейтропениянеонатальная изоиммунная нейтропенияидиосинкразияTRALI-синдромтяжелая хроническая нейтропенияtransient neutropeniachronic autoimmune neutropenianeonatal isoimmune neutropeniaidiosyncrasyTRALI-syndromesevere chronic neutropeniaReferencesФиногенова Н.А. Болезни лейкоцитов. Практическое руководство по детским болезням. Под общ. ред. А.Г. Румянцева. Т. IV. Гематология/ онкология детского возраста. М.: Медпрактика, 2004. [Finogenova N.A. Diseases of white blood cells. A practical guide to pediatric diseases. Ed. by A.G. Rumyantsev Vol. IV Hematology/Oncology pediatric. Moscow: Medpraktika, 2004. (In Russ.)].Финогенова Н.А. Болезни лейкоцитов. Практическое руководство по детским болезням. Под общ. ред. А.Г. Румянцева. Т. IV. Гематология/ онкология детского возраста. М.: Медпрактика, 2004. [Finogenova N.A. Diseases of white blood cells. A practical guide to pediatric diseases. Ed. by A.G. Rumyantsev Vol. IV Hematology/Oncology pediatric. Moscow: Medpraktika, 2004. (In Russ.)].Володин Н.Н., Румянцев А.Г., Щербина А.Ю. Применение рекомбинантных гранулоцитарных колониестимулирующих факторов у новорожденных. Показания и клинические рекомендации. Вопросы практической педиатрии 2012;7(4):44–9. [Volodin N.N., Rumyantsev A.G., Shcherbina A.Yu. Use of recombinant granulocyte colony-stimulating factors in the newborn. Indications and clinical guidelines. Voprosy prakticheskoy pediatrii = Issues of Practical Pediatrics 2012;7(4):44–9.(In Russ.)].Володин Н.Н., Румянцев А.Г., Щербина А.Ю. Применение рекомбинантных гранулоцитарных колониестимулирующих факторов у новорожденных. Показания и клинические рекомендации. Вопросы практической педиатрии 2012;7(4):44–9. [Volodin N.N., Rumyantsev A.G., Shcherbina A.Yu. Use of recombinant granulocyte colony-stimulating factors in the newborn. Indications and clinical guidelines. Voprosy prakticheskoy pediatrii = Issues of Practical Pediatrics 2012;7(4):44–9.(In Russ.)].Newburger P.E., Dale D.C. Evaluation and management of patients with isolated neutropenia. Sem Hematol 2013;50(3): 198–206.Newburger P.E., Dale D.C. Evaluation and management of patients with isolated neutropenia. Sem Hematol 2013;50(3): 198–206.Hsieh M.M., Everhart J.E., ByrdHolt D.D. et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007;146:486–92.Hsieh M.M., Everhart J.E., ByrdHolt D.D. et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007;146:486–92.Reich D., Nalls M.A., Kao W.H. et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 2009;5:e1000360. 6. Husain E.H., Mullah-Ali A., Al-Sharidah S. et al. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J 2012;31:575–7.Reich D., Nalls M.A., Kao W.H. et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 2009;5:e1000360. 6. Husain E.H., Mullah-Ali A., Al-Sharidah S. et al. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J 2012;31:575–7.Savard M., Gosselin J. Epstein–Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Res 2006;119:134–45.Savard M., Gosselin J. Epstein–Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Res 2006;119:134–45.Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005;7:187–96.Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005;7:187–96.Dale D.C., Bolyard A.A., Schwinzer B.G. et al. The Severe Chronic Neutropenia International Registry: 10-Year follow-up report. Support Cancer Ther 2006;3:220–31.Dale D.C., Bolyard A.A., Schwinzer B.G. et al. The Severe Chronic Neutropenia International Registry: 10-Year follow-up report. Support Cancer Ther 2006;3:220–31.Bux J. Human neutrophil alloantigens. Vox Sang 2008;94:277–85.Bux J. Human neutrophil alloantigens. Vox Sang 2008;94:277–85.Clay M.E., Schuller R.M., Bachowski G.J. Granulocyte serology: current concepts and clinical signifcance. Immunohematol 2010;26:11–21.Clay M.E., Schuller R.M., Bachowski G.J. Granulocyte serology: current concepts and clinical signifcance. Immunohematol 2010;26:11–21.Bruin M., Dassen A., Pajkrt D. et al. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 2005;88:52–9.Bruin M., Dassen A., Pajkrt D. et al. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 2005;88:52–9.Bux J., Behre G., Jaeger G., Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181–6.Bux J., Behre G., Jaeger G., Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181–6.Kwon S.W., Procter J., Dale J.K. et al. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 2003;85:307–12.Kwon S.W., Procter J., Dale J.K. et al. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 2003;85:307–12.Podjasek J.C., Abraham R.S. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol 2012;3:189.Podjasek J.C., Abraham R.S. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol 2012;3:189.Fung Y.L., Silliman C.C. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009;23:266–83.Fung Y.L., Silliman C.C. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009;23:266–83.Beekman R., Valkhof M.G., Sanders M.A. et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012;119:5071–7.Beekman R., Valkhof M.G., Sanders M.A. et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012;119:5071–7.Skokowa J., Steinemann D., Makaryan V. et al. RUNX1 mutations are the most frequent leukemia associated mutations in congenital neutropenia patients. ASH Annual Meeting Abstracts 2012;120:7.Skokowa J., Steinemann D., Makaryan V. et al. RUNX1 mutations are the most frequent leukemia associated mutations in congenital neutropenia patients. ASH Annual Meeting Abstracts 2012;120:7.de Alarcon P.A., Goldberg J., Nelson D.A., Stockman J.A. III. Chronic neutropenia: diagnostic approach and prognosis. Am J Pediatr Hematol Oncol 1983;5:3–9.de Alarcon P.A., Goldberg J., Nelson D.A., Stockman J.A. III. Chronic neutropenia: diagnostic approach and prognosis. Am J Pediatr Hematol Oncol 1983;5:3–9.Boxer L.A., Bolyard A.A., Schwinzer B. et al. Antineutrophil antibodies lead to mistaken identity in severe congenital neutropenia. Blood 2005;106:385.Boxer L.A., Bolyard A.A., Schwinzer B. et al. Antineutrophil antibodies lead to mistaken identity in severe congenital neutropenia. Blood 2005;106:385.Riera N.E., Rosso S.M., Galan V. et al. Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia. Int J Lab Hematol 2010;32:96–105.Riera N.E., Rosso S.M., Galan V. et al. Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia. Int J Lab Hematol 2010;32:96–105.Muschter S., Berthold T., Greinacher A. Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol 2011;18:452–60.Muschter S., Berthold T., Greinacher A. Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol 2011;18:452–60.Dale D.C., Bonilla M.A., Davis M.W. et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood1993;81:2496–502.Dale D.C., Bonilla M.A., Davis M.W. et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood1993;81:2496–502.Rosenberg P.S., Zeidler C., Bolyard A.A. et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010;150:196–9.Rosenberg P.S., Zeidler C., Bolyard A.A. et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010;150:196–9.Rosenberg P.S., Alter B.P., Bolyard A.A. et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628–35.Rosenberg P.S., Alter B.P., Bolyard A.A. et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628–35.Makaryan V., Zeidler C., Bolyard A.A. et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE. ASH Annual Meeting Abstracts 2012;120:3275.Makaryan V., Zeidler C., Bolyard A.A. et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE. ASH Annual Meeting Abstracts 2012;120:3275.Beaupain B., Leblanc T., Reman O. et al. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. Pediatr Blood Cancer 2009;53: 1068–73.Beaupain B., Leblanc T., Reman O. et al. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. Pediatr Blood Cancer 2009;53: 1068–73.Fioredda F., Calvillo M., Lanciotti M. et al. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer 2010;54:465–7.Fioredda F., Calvillo M., Lanciotti M. et al. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer 2010;54:465–7.

The authors declare that there are no conflicts of interest present.